Catalyst Biosciences (CBIO) Financials

$18.54

$0.61 (3.40%)

As on 02-Sep-2026 16:00EDT

Market cap

$659 Mln

Revenue (TTM)

$42 Mln

P/E Ratio

--

P/B Ratio

4.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	42.45	10.84	--	0.01	0.08	1.16
Cost of Revenue	1.68	0.08	0.04	0.15	1.03	--
Gross Profit	40.82	10.84	-0.04	0.01	0.08	1.16
Operating Expenses	180.35	163.48	49.90	39.29	47.48	64.61
Operating Profit (EBIT)	-168.47	-152.63	-49.90	-39.28	-47.40	-63.45
Other Income	--	--	--	--	--	--
Profit before Tax	-163.12	-151.94	-48.52	-36.90	-46.69	-63.43
Provision for Tax	2.00	2.00	--	--	--	--
Profit after Tax (Net Income)	-162.98	-153.94	-48.52	-36.90	-46.69	-63.43
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	163.26	203.01	-15.48	38.41	42.93	81.60
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.97	1.21	41.48	0.07	--	0.92
Current Liabilities	18.54	36.07	9.61	6.84	8.88	11.82
Total Liabilities	201.30	240.29	35.62	45.32	51.81	94.35

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	3.75	3.64	0.81	1.53	1.10	3.56
Current Assets	179.01	236.66	34.80	43.79	50.71	90.79
Total Assets	201.30	240.29	35.62	45.32	51.81	94.35
Total Debt*	1.44	1.64	37.48	0.81	0.92	1.92
Net Current Assets	160.47	200.58	25.19	--	--	--

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-71.53	-31.10	-34.88	-46.46	-57.49
Cash Flow from Investing Activities	--	-72.92	0.02	-0.02	-0.08	-0.01
Cash from Financing Activities	--	322.98	0.01	28.82	4.16	10.72
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-7.58	-7.63	-75.25	-57.31	-88.16	-121.95
Cash EPS ($)	--	-7.63	-75.25	-57.31	-88.16	-121.95
Adjusted Book Value ($)	--	10.06	--	59.66	81.06	156.90
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.55	-48.23	-54.17	-87.72	-110.54
Free Cash Flow per Share ($)	--	-7.16	-48.24	-54.20	-87.88	-110.56

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-135.84	-158.51	-88.84	-73.31	-59.12
ROE (%)	-88.99	-164.18	-423.13	-90.72	-74.98	-60.46
ROA (%)	-86.81	-111.59	-119.91	-75.98	-63.89	-53.48
EBIT Margin (%)	-384.30	-1,381.01	--	-392,746.56	-63,203.84	-5,470.69
Net Margin (%)	-383.95	-1,419.61	--	-368,994.20	-62,251.74	-5,468.98
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	-0.87	-0.94	-0.89
EBIT Growth (%)	-275.40	-238.75	-12.56	17.15	25.29	-23.18
Net Profit Growth (%)	-152.17	-217.25	-31.50	20.97	26.39	-24.30
EPS Growth (%)	88.89	0.90	-0.31	0.35	0.28	-0.15
Book Value Growth (%)	-85.19	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.55	--	--	-0.01	0.00
Price / Book Value	4.18	1.18	--	--	0.01	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	-0.18	--	--	0.99	1.40
Close Price ($)	18.00	11.86	--	--	4.90	0.59
High Price ($)	27.41	21.40	--	--	5.76	4.85
Low Price ($)	8.72	9.81	--	--	0.22	0.58
Market Cap ($ Cr)	659.36	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	-2.42	0.02	0.02	0.02
Short term debt to equity ratio	0.00	0.00	0.00	0.02	0.02	0.01
Current Ratio	9.66	6.56	3.62	6.41	5.71	7.68
Quick Ratio	9.66	--	--	--	--	--
Interest Coverage	-49.07	-68.54	-51.89	--	--	--

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	165.99	--	1,758.20	192.02	0.12
Asset Turnover	0.23	0.08	--	0.00	0.00	0.01
Receivable days	--	305.44	--	5,841.00	353.96	0.55
Inventory Days	--	--	--	--	--	--
Payable days	--	21,967.18	5,062.84	2,189.94	544.57	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.